Table 2.

Comparison of clinical outcomes between the oral glucose and placebo groups (N = 400)

	50% Dextrose solution (n = 205)	Placebo solution (n = 195)	p*
First BG level (mg/dL)	37.0 [33.0, 39.0]	37.0 [33.0, 39.0]	0.47
BG levels after the first treatment (mg/dL)	68.0 [56.8, 77.3]	60.0 [51.0, 74.0]	< 0.01*
< 40	7/205 (3.4)	9/195 (4.6)	0.73
< 25	1/205 (0.5)	1/195 (0.5)	1.00
Incremental BG level after the first treatment (mg/dL)	30.0 [20.0, 42.0]	23.0 [15.0, 36.0]	< 0.01*
Incremental BG level after any treatment† (mg/dL)	28.0 [18.0,40.0]	22.5 [14.0, 35.0]	< 0.01*
Number of solution doses needed	1 [1, 1]	1 [1, 1]	0.39
≥ 2	23 (11.2)	17 (8.9)	0.48
Intravenous dextrose therapy	10 (4.9)	17(8.7)	0.18
Hyperglycemia (> 180 mg/dL)	0 [0, 0]	0 [0, 0]	1.00
Duration of birth hospitalization (days)	5 [4, 7]	5 [4, 7]	0.06

Data are presented in number (percentage) or median [25th,75th percentile]

†Two post-treatment BG measurements were not performed in the placebo group after the 2nd and 3rd doses

^*p-value less than 0.05 is considered statistically significant

BG blood glucose